Venus Remedies Limited (NSE: VENUSREM, BSE: 526953), a leading research-driven global pharmaceutical company, has joined the United Nations Global Compact (UNGC), the world’s largest corporate sustainability initiative. With this strategic move, the company aligns its operations and strategies with the UNGC’s Ten Principles on human rights, labour,
The UNICEF order for ceftriaxone supply is an endorsement of Venus Remedies’ exceptional quality standards and its position as a trusted partner in global healthcare supply chains The company also secures a mandate from the world's oldest international public health agency for supplying essential
Venus Remedies makes its maiden entry into Azerbaijan’s pharmaceutical market The company has over a dozen marketing authorisations for enoxaparin worldwideVenus Remedies Limited, a leading fixed-dosage injectable manufacturer, has reached a significant milestone with a marketing authorisation from Azerbaijan for the first time for
